ArticleOncotarget2019

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma.

Celina Ang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.